Novo Nordisk’s Wegovy Pill Lands in Germany | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded01 Sep 2026

Publisherfeeds.acast.com ↗

Handlerec:20215028

Show notes

Novo Nordisk just dropped its Wegovy pill in Germany — the first EU country to get it — marking a major leap in their fight for oral obesity dominance. Same active ingredient as their injectable hits, this pill could capture nearly 90% of the oral market, even as rivals like Eli Lilly push back with Zepbound and Mounjaro. Priced similarly to injections (€170–280), it’s already rolling out in the U.S., UK, and UAE, with analysts forecasting a $100B+ market by 2030. With pills projected to make up over a third of all GLP-1 use by then, Novo’s move signals a shift toward convenience — and they’re holding strong as Lilly gears up for global expansion. Big news drops September 21st at their capital markets day. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3a31eadd3e6c6c49

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.